Data
Prevalence of Hepatitis C Virus in an Endemic Area of Thailand: Burden Assessment toward HCV Elimination
Wasitthankasem R et al. Am J Trop Med Hyg
Resources search
Filter
Displaying 1 - 12 of 565
-
-
Health economics
Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, era, a population-based study
Wasitthankasem R, , et al. PLoS One -
Policy
Report of the WHO global partners' meeting on hepatitis elimination
-
Policy
Access to hepatitis C testing and treatment for people who inject drugs and people in prisons- a global perspective
World Health Organization -
Health economics
Pricing viral hepatitis as part of universal health coverage
Lancet Global Health -
Health economics
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning
Clinical Infectious Diseases, , ciaa134, -
Health economics
Securing sustainable funding for viral hepatitis elimination plans
Liver Int. 2020; 40: 260– 270 -
Data
Viral Hepatitis in Mongolia: Situation and Response 2015
WHO WPRO -
Data
WHO Progress Report on Access to Hepatitis C Treatment
WHO -
Data
Estimated prevalence of Hepatitis C Virus infection in Canada, 2011
Public Health Agency of Canada. CCDR Volume 40-19 -
Data
Report on hepatitis B and C in Canada: 2017
Public Health Agency of Canada -
Data
Monitoring hepatitis C treatment uptake in Australia
. The Kirby Institute